See more : Solitario Zinc Corp. (SLR.TO) Income Statement Analysis – Financial Results
Complete financial analysis of SciVision Biotech Inc. (1786.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SciVision Biotech Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Aeeris Limited (AER.AX) Income Statement Analysis – Financial Results
- Syndax Pharmaceuticals, Inc. (SNDX) Income Statement Analysis – Financial Results
- Brunswick Corporation 6.375% No (BC-PC) Income Statement Analysis – Financial Results
- Black Iron Inc. (BKIRF) Income Statement Analysis – Financial Results
- China Carbon Graphite Group, Inc. (CHGI) Income Statement Analysis – Financial Results
SciVision Biotech Inc. (1786.TW)
About SciVision Biotech Inc.
SciVision Biotech Inc. manufactures and sells hyaluronic acid products in Taiwan. It offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. The company was founded in 2001 and is based in Kaohsiung, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 712.99M | 557.35M | 505.54M | 466.88M | 437.87M | 329.58M | 258.42M | 228.30M | 264.84M | 158.28M | 200.51M | 200.68M | 143.27M | 66.22M | 15.68M |
| Cost of Revenue | 200.49M | 185.48M | 163.70M | 123.60M | 132.42M | 112.66M | 105.59M | 101.15M | 109.27M | 78.80M | 84.81M | 77.50M | 52.37M | 43.12M | 28.10M |
| Gross Profit | 512.49M | 371.87M | 341.84M | 343.28M | 305.46M | 216.92M | 152.83M | 127.16M | 155.58M | 79.49M | 115.70M | 123.18M | 90.90M | 23.09M | -12.42M |
| Gross Profit Ratio | 71.88% | 66.72% | 67.62% | 73.53% | 69.76% | 65.82% | 59.14% | 55.70% | 58.74% | 50.22% | 57.70% | 61.38% | 63.45% | 34.87% | -79.20% |
| Research & Development | 53.42M | 52.46M | 65.94M | 59.78M | 43.25M | 47.98M | 39.25M | 30.50M | 24.86M | 37.24M | 26.41M | 26.94M | 17.73M | 20.03M | 21.13M |
| General & Administrative | 82.77M | 74.62M | 59.88M | 52.97M | 53.20M | 43.99M | 46.58M | 38.85M | 49.41M | 38.73M | 33.66M | 25.66M | 21.82M | 17.12M | 15.82M |
| Selling & Marketing | 176.67M | 110.18M | 94.07M | 83.89M | 74.82M | 44.30M | 35.85M | 30.00M | 41.16M | 38.86M | 25.82M | 19.57M | 15.43M | 13.63M | 11.29M |
| SG&A | 259.44M | 184.80M | 153.95M | 136.87M | 128.02M | 88.29M | 82.43M | 68.85M | 90.57M | 77.60M | 59.48M | 45.22M | 37.25M | 30.75M | 27.12M |
| Other Expenses | 0.00 | 36.73M | -324.00K | 13.34M | 6.49M | 15.12M | -4.29M | -53.81M | 6.86M | 13.23M | 1.59M | 95.00K | 7.47M | 12.36M | 8.60M |
| Operating Expenses | 312.86M | 237.26M | 219.89M | 196.64M | 171.27M | 136.26M | 121.68M | 99.34M | 115.43M | 114.84M | 85.89M | 72.16M | 54.98M | 50.78M | 48.25M |
| Cost & Expenses | 513.35M | 422.74M | 383.60M | 320.24M | 303.69M | 248.92M | 227.27M | 200.49M | 224.70M | 193.63M | 170.70M | 149.67M | 107.35M | 93.91M | 76.35M |
| Interest Income | 14.90M | 4.88M | 2.63M | 1.92M | 4.11M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 420.00K | 321.00K | 53.00K | 66.00K |
| Interest Expense | 8.22M | 6.46M | 8.07M | 7.47M | 6.40M | 2.68M | 4.19M | 5.14M | 233.00K | 17.00K | 31.00K | 3.00K | 266.00K | 1.55M | 1.65M |
| Depreciation & Amortization | 63.13M | 62.06M | 53.02M | 15.31M | 14.51M | 20.63M | 20.94M | 21.23M | 19.85M | 19.14M | 22.71M | 21.56M | 22.41M | 21.28M | 19.44M |
| EBITDA | 281.35M | 238.28M | 177.27M | 177.21M | 155.18M | 116.42M | 47.80M | -4.76M | 66.85M | -2.99M | 54.11M | 73.25M | 66.44M | 8.66M | -31.22M |
| EBITDA Ratio | 39.46% | 42.75% | 35.07% | 37.96% | 35.44% | 35.32% | 18.50% | -2.09% | 25.24% | -1.89% | 26.98% | 35.98% | 45.98% | 13.07% | -201.00% |
| Operating Income | 199.64M | 176.23M | 124.25M | 161.90M | 140.68M | 80.66M | 26.86M | -25.99M | 47.01M | -22.13M | 31.40M | 50.65M | 43.47M | -12.63M | -50.96M |
| Operating Income Ratio | 28.00% | 31.62% | 24.58% | 34.68% | 32.13% | 24.47% | 10.39% | -11.39% | 17.75% | -13.98% | 15.66% | 25.24% | 30.34% | -19.07% | -324.95% |
| Total Other Income/Expenses | 10.36M | 38.94M | -5.89M | 5.85M | 90.00K | 12.44M | -8.48M | -58.94M | 6.63M | 13.21M | 1.55M | 620.00K | 7.84M | 13.52M | 8.13M |
| Income Before Tax | 210.00M | 173.55M | 116.06M | 152.49M | 134.28M | 93.10M | 22.67M | -31.13M | 46.77M | -22.15M | 31.36M | 51.63M | 43.76M | -14.17M | -52.54M |
| Income Before Tax Ratio | 29.45% | 31.14% | 22.96% | 32.66% | 30.67% | 28.25% | 8.77% | -13.63% | 17.66% | -13.99% | 15.64% | 25.73% | 30.54% | -21.40% | -335.06% |
| Income Tax Expense | 32.10M | 31.83M | 14.34M | 24.48M | 13.57M | 6.23M | 5.53M | -4.87M | -8.07M | 0.00 | -8.99M | -10.80M | -7.40M | -7.31M | -9.00K |
| Net Income | 177.90M | 141.72M | 101.72M | 128.01M | 120.70M | 86.87M | 17.14M | -26.26M | 54.84M | -22.15M | 40.35M | 62.43M | 51.16M | -6.86M | -52.54M |
| Net Income Ratio | 24.95% | 25.43% | 20.12% | 27.42% | 27.57% | 26.36% | 6.63% | -11.50% | 20.71% | -13.99% | 20.12% | 31.11% | 35.71% | -10.37% | -335.00% |
| EPS | 2.66 | 2.14 | 1.54 | 1.93 | 1.84 | 1.46 | 0.28 | -0.44 | 0.90 | -0.36 | 0.75 | 1.18 | 1.00 | -0.16 | -1.26 |
| EPS Diluted | 2.33 | 1.92 | 1.51 | 1.88 | 1.78 | 1.46 | 0.28 | -0.44 | 0.89 | -0.36 | 0.75 | 1.18 | 1.00 | -0.16 | -1.26 |
| Weighted Avg Shares Out | 66.85M | 66.19M | 66.19M | 66.19M | 65.77M | 59.56M | 59.99M | 59.99M | 61.01M | 60.95M | 52.84M | 52.74M | 51.10M | 43.84M | 41.54M |
| Weighted Avg Shares Out (Dil) | 76.44M | 74.66M | 70.98M | 70.92M | 70.37M | 59.63M | 60.03M | 59.99M | 61.06M | 62.20M | 53.92M | 52.88M | 51.10M | 43.84M | 41.54M |
No news found for: 1786.TW
Source: https://incomestatements.info
Category: Stock Reports